Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas

Table 5

Univariate analysis of clinical features in primary hepatic neuroendocrine carcinomas.

Variables	Survival status			values^a
	Death	Survival
Gender			0. 081	0.776
Female	3	2
Male	6	2
Age (years)			2.212	0.137
≤50	5	1
>50	4	3
ALT (U/L)			0.013	0.910
≤40	2	3
>40	7	1
AST (U/L)			0.653	0.419
≤40	1	3
>40	8	1
HB (G/L)			1.090	0.296
≤110	3	2
>110	6	2
Albumin (G/L)			0.141	0.707
≤35	4	2
>35	5	2
ALP (U/L)			0.806	0.369
≤105	3	3
>105	6	1
GGT (U/L)			0.918	0.338
≤50	2	2
>50	7	2
Location			2.518	0.113
Left	0	3
Right	8	1
Unknown	1	0
Number			0.151	0.698
Single	6	4
Multiple	3	0
Diameter			0.044	0.835
≤5 (cm)	3	0
>5 (cm)	4	4
Unknown	2	0
CA125 (μg/mL)			0.296	0.586
≤35	7	4
>35	2	0
CA19-9 (μg/mL)			0.711	0.399
≤35	7	2
>35	2	2
HbsAg			0.412	0.521
Positive	1	1
Negative	8	3
Treatment			4.585	0.032
Operation	2	2
Others	7	2

ALT = alanine aminotransferase, AST = aspartate aminotransferase, HB = hemoglobin, ALP = alkaline phosphatase, GGT = γ-glutamyl transpeptidase, CA125 = carbohydrate antigen 125, CA19-9 = carbohydrate antigen 19-9, HbsAg = hepatitis B virus surface antigen. ^aKaplan–Meier survival curve and log-rank test. indicates .